Interleukin-33 Promotes Cell Survival via p38 MAPK-Mediated Interleukin-6 Gene Expression and Release in Pediatric AML.

Front Immunol · 2020 · PMC7726021 · PMID 33324412

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Interestingly, cells treated with the combination of IL-33 with anti-IL-33 antibody showed a trend towards decreased IL-6 mRNA expression as compared to IL-33 treatment alone, although this difference was not statistically significant in either BM or PB ( Figures 2C, D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.